From: deputyfife23x@gmail.com   
      
   Health Notes: Mayo gets grant to study role of vascular disease in   
   Alzheimer's, other dementias   
   By Charlie Patton Tue, Nov 17, 2015 @ 3:35 pm | updated Tue, Nov 17, 2015 @   
   4:40 pm   
      
   The entrance of the Mayo Clinic Hospital on the Mayo campus on San Pablo Road   
   in Jacksonville.  Times-Union file   
   Times-Union file   
   The entrance of the Mayo Clinic Hospital on the Mayo campus on San Pablo Road   
   in Jacksonville.   
   Researchers at the Mayo Clinic in Jacksonville have been awarded a $5.3   
   million grant from the National Institutes of Health (NIH) to identify   
   vascular risk factors in aging and dementia, and translate that knowledge into   
   studying potential targets for    
   treatment.   
   The grant is one of the first awarded as part of the National Alzheimer's   
   Project Act, which called for an aggressive and coordinated national   
   Alzheimer's disease plan.   
      
   The first goal of the national plan is to prevent and effectively treat   
   Alzheimer's disease by 2025.   
      
   Guojun Bu, a molecular neuroscientist, and Nilüfer Ertekin-Taner, a   
   neurologist and neurogeneticist, are the principal investigators for the study.   
      
   Both are based on Mayo Clinic's Jacksonville campus. Several additional   
   investigators work for Mayo in Jacksonville and Rochester, Minn., campuses, as   
   well as Mount Sinai School of Medicine in New York.   
      
   The NIH grant will fund a five-year study of the association between vascular   
   disease and Alzheimer's and related dementias. Researchers also will look at   
   genetic risk factors and the higher risk women are at in the development of   
   Alzheimer's.   
      
   The study will include clinical data and biomedical samples from 400 living   
   patients and will incorporate brain pathology data from 400 brains provided by   
   the Mayo Clinic Brain Bank on the Jacksonville campus, which holds one of the   
   world's largest    
   collections of donated brains for medical study.   
      
       
      
   New treatment to fight brain cancer   
      
   A new treatment option at Baptist MD Anderson Cancer Center could help extend   
   the life of patients newly diagnosed with glioblastoma multiforme, an   
   aggressive form of brain cancer.   
      
   The U.S. Food and Drug Administration recently approved an expanded indication   
   for the Optune device to treat patients with newly diagnosed glioblastoma   
   multiforme. Optune was initially approved in 2011 to treat patients with   
   glioblastoma multiforme that    
   recurred or progressed after chemotherapy.   
      
   With this expanded indication, Optune can be used as part of standard   
   treatment before the disease progresses.   
      
   To make an appointment for cancer treatment or for more information, go to   
   BaptistMDAnderson.com or call (844) 632-2278.   
      
       
      
   Baptist hospitals receive award   
      
   Baptist Medical Center Jacksonville and Baptist Medical Center South are   
   recipients of the Women's Choice Award for America's Best Stroke Centers.   
      
   Stroke is the fifth-leading cause of death in the U.S. and the leading cause   
   of adult disability, according to the American Heart Association and American   
   Stroke Association.   
      
   Hospitals earning the 2015 America's Best Stroke Centers Award must be   
   certified by the Joint Commission as an Advanced Primary Stroke Center.   
      
   In addition to the Joint Commission Accreditation, only hospitals with a   
   recommendation rating above the national average will receive the Women's   
   Choice Award.   
      
      
   http://jacksonville.com/news/health-and-fitness/2015-11-17/story   
   health-notes-mayo-gets-grant-study-role-vascular-disease   
      
   --- SoupGate-Win32 v1.05   
    * Origin: you cannot sedate... all the things you hate (1:229/2)